Patient dies after IVF treatment
By BBC News,
BBC News
| 08. 10. 2006
Officials at the Leicester Royal Infirmary confirmed a patient had lost her life on Monday after undergoing IVF treatment at the hospital.
It is understood she developed complications but a cause of death has not yet been identified.
A spokesperson from the hospital said the Human Fertilisation and Embryology Authority had been informed.
The case has also been reported to the coroner and no further details about the woman have been released.
A spokesperson from the University Hospitals of Leicester NHS Trust, said: "Tragically a patient undergoing IVF treatment has subsequently died.
"The cause of death is yet to be determined and a full investigation is underway."
Dr Mark Hamilton, chairman of the British Fertility Society, said: "The procedures used in clinics are very safe and serious complications for patients are extremely rare."
He said that published statistics on Assisted Reproduction in Europe, presented earlier this year at the European Society for Human Reproduction and Embryology, showed that in 2002, there were two maternal deaths out of 224,000 procedures.
Worldwide more than three million babies have been born as a...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...